DiscoverPrecisionA Novel Vaccine Trial for Children with Rare Brain Cancer, DIPG with Ashley Plant-Fox, MD and Michael DeCuypere, MD, PhD
A Novel Vaccine Trial for Children with Rare Brain Cancer, DIPG with Ashley Plant-Fox, MD and Michael DeCuypere, MD, PhD

A Novel Vaccine Trial for Children with Rare Brain Cancer, DIPG with Ashley Plant-Fox, MD and Michael DeCuypere, MD, PhD

Update: 2024-06-04
Share

Description

Diffuse intrinsic pontine glioma, known as DIPG, is a rare and aggressive type of pediatric cancer that forms in the brainstem, resulting in approximately 200 to 300 new cases in the United States each year. Fortunately, investigators at Lurie Children's Hospital are paving the way to breakthrough treatment for children with DIPG. In this episode, Lurie Children's physicians Dr. Ashley Plant-Fox and Dr. Michael DeCuypere discuss the progress of this first-of-its-kind, phase 1 clinical trial for DIPG that has been open since January of 2022 and offers hope for a disease that currently has no curative options.

 

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

A Novel Vaccine Trial for Children with Rare Brain Cancer, DIPG with Ashley Plant-Fox, MD and Michael DeCuypere, MD, PhD

A Novel Vaccine Trial for Children with Rare Brain Cancer, DIPG with Ashley Plant-Fox, MD and Michael DeCuypere, MD, PhD

Ann & Robert H. Lurie Children's Hospital of Chicago